Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:El-Erian: Fed Is Acting as Experimental Doctor Not Rated 0.0 Email Routing List Email & Route  Print Print
Friday, August 23, 2013

El-Erian: Fed Is Acting as Experimental Doctor

News summary by MFWire's editors

Pimco [profile] executives just can't stop talking about the Fed tapering. Pimco chief executive and co-chief executive officer, Mohamed El Erian spoke on recent Fed actions at the National Press Club in Washington DC, InvestmentNews' Mark Schoeff reports. Schoeff quotes El Erian as saying, "We are in a period where the Fed, not by choice but by necessity is using experimental policies that haven't been tested…It's like a doctor that gives you medicine--because she or he has to do it--that has not been clinically tested."

MoneyNews', Dan Weil writes that El-Erian also stated interest rates were unlikely to rise until at least 2016, though the tapering may begin new month.

Adding his voice to the fray, Scott Mather, head of global portfolio management at Pimco, said the selloff in Treasuries was overdone because markets misunderstood the Fed's statement on bond purchases, Bloomberg's Candice Zachariahs reports.

Mather told Zachariahs that, "We think it's more likely that the Fed is at zero for a couple of years and the markets are, in our view, overshooting in bringing forward rate hikes at a time when both inflation and growth are well below the Fed's targets."

Zachariahs writes that, according to Mather, the mutual fund giant favors strategies that take advantage of the surge both in the U.S. and globally, Mather was quoted as saying, "…so duration is attractive but curve is even more attractive in our view."

To read more, click here, here, and here

Edited by: Casey Quinlan


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. IMEA CMO Roundtable, May 14
  2. Envestnet Elevate 2024, May 14-15
  3. The Expect Miracles Foundation 5th Annual Distance Challenge, May 14-21
  4. ALFI Golf Tournament In New York, May 14
  5. MFDF webinar - The Improvisational Leader Callback Session, May 14
  6. ICI & ASECA: Celebrating 100 Years of the Mutual Fund, May 14
  7. WE U.S. - 10th Annual Event at InsideETFs, May 14
  8. WE Boston - Women's Initiative Joint Spring Networking Reception, May 15
  9. SEC IM 2024 Conference on Emerging Trends in Asset Management, May 16
  10. MFDF In Focus: Making Sense of ESG - A Morningstar Guide, May 16
  11. ALFI Roadshow to the USA, May 16
  12. 2024 ICI Leadership Summit, May 21-23
  13. MFDF webinar - Mutual Fund Director Compensation: the MPI Annual Survey (2024), May 21
  14. Schwab Institutional Investor Day, May 22
  15. MFDF Conference of Fund Leaders Forum, June 5
  16. MFDF in-person outreach: Continuing Regulatory Impacts on Fund Boards, June 11
  17. 2024 Nicsa Fearless Leadership Symposium, June 12
  18. 2024 MMI Leadership Pathway Seminar, Jun 12-14
  19. MFDF webinar - Digital Assets in the Fund Space (Part 1 of 2), June 12
  20. MFDF webinar - Lessons Learned from the Regional Bank Volatility and the Impact on Registered Funds, June 18
  21. MFDF Director Discussion Series - Open Forum (Philadelphia), June 20
  22. New York YPEM Cornhole Classic, June 25
  23. Morningstar Investment Conference Conference 2024, Jun 26-27
  24. MFDF webinar - Mid-Year Tax Update for Registered Investment Companies, July 16
  25. MFDF Director Discussion Series - Open Forum via Zoom, July 17
  26. MFDF Director Discussion Series - Open Forum (New York), July 23




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use